Adam Hoffman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adam Hoffman has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Amy S. Gargis
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
1 shared publication - Ashley Paulick
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
1 shared publication Bettina Bankamp
Affiliation COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, United States of America
1 shared publicationCaitlin Biedron
Affiliation COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, United States of America
1 shared publication- Catherine C. Espinosa
Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
1 shared publication Cdc Covid-19 Emergency Response Ga-10 Field Team
¶Membership of the CDC Surge Diagnostic Testing Laboratory, CDC COVID-19 Emergency Response GA-10 Field Team listed in the Acknowledgments
1 shared publication
Latest Publications
- Open Access
- 9 March 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (3) , e0264085
Specimen self-collection for SARS-CoV-2 testing: Patient performance and preferences—Atlanta, Georgia, August-October 2020
Self-collected specimens can expand access to SARS-CoV-2 testing. At a large inner-city hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before healthcare workers collected nasopharyngeal swab (NPS) samples on the same day. To characterize patient preferences for self-collection, this investigation explored ability, comfort, and ease of ANS and saliva self-collection for SARS-CoV-2 testing along with associated patient characteristics, including medical history and symptoms of COVID-19. With nearly all participants successfully submitting a specimen, favorable ratings from most participants (at least >79% in ease and comfort), and equivocal preference between saliva and ANS, self-collection is a viable SARS-CoV-2 testing option.
- 9 March 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (3) , e0264085
Open AccessSpecimen self-collection for SARS-CoV-2 testing: Patient performance and preferences—Atlanta, Georgia, August-October 2020
Self-collected specimens can expand access to SARS-CoV-2 testing. At a large inner-city hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before healthcare workers collected nasopharyngeal swab (NPS) samples on the same day. To characterize patient preferences for self-collection, this investigation explored ability, comfort, and ease of ANS and saliva self-collection for SARS-CoV-2 testing along with associated patient characteristics, including medical history and symptoms of COVID-19. With nearly all participants successfully submitting a specimen, favorable ratings from most participants (at least >79% in ease and comfort), and equivocal preference between saliva and ANS, self-collection is a viable SARS-CoV-2 testing option.